Quarterly report pursuant to Section 13 or 15(d)

Equity (Details)

v3.22.2.2
Equity (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Aug. 05, 2022
Jul. 25, 2022
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Jun. 08, 2022
Equity (Details) [Line Items]              
Share price (in Dollars per share)   $ 0.65          
Common stock, issued (in Shares) 320,513 5,736,452 250,000   250,000    
Purchase price (in Dollars per share) $ 0.78            
Received proceeds         $ 250,000    
Shares fair market value         340,950    
Stock-based compensation expense     $ 110,442 $ 188,859 389,066 $ 586,573  
Reduced accrued liabilities     30,000   30,000    
Recorded prepaid expense     19,680   19,680    
Principal amount   $ 3,718,943          
Unpaid interest   9,751          
Conversion agreement   $ 344,264          
Debt settlement agreement description   On July 25, 2022, the Company and Mr. Lu entered into and closed a Debt Settlement Agreement and Release pursuant to which the Company settled $2,440,262 debt owed under the Line of Credit and unpaid interest of $448,331 by issuance of 4,443,990 shares of common stock of the Company (see Note 10 - Line of Credit). The total amount of the debt settled of $2,888,593 exceeded the fair market value of the shares issued by $888,353 which was treated as a capital transaction due to Mr. Lu's relationship with the Company.           
Stock options outstanding     303,800   303,800    
Stock options exercisable         $ 292,597    
Volatility rate         111.94%    
Dividend yield         0.00% 0.00%  
Aggregate fair value       594,401   $ 594,401  
Stock warrants exercisable     $ 0   $ 0    
Common Stock [Member]              
Equity (Details) [Line Items]              
Issuance of common stock for services         408,957    
Common Shares Issued for Services [Member]              
Equity (Details) [Line Items]              
Stock-based compensation expense         $ 291,270    
Minimum [Member]              
Equity (Details) [Line Items]              
Volatility rate         74.80% 121.52%  
Risk-free rate         1.37% 0.33%  
Expected life         3 years 3 years  
Maximum [Member]              
Equity (Details) [Line Items]              
Volatility rate         117.46% 128.42%  
Risk-free rate         3.56% 0.80%  
Expected life         5 years 5 years  
2022 Warrant [Member]              
Equity (Details) [Line Items]              
Acquire an aggregate shares of common stock (in Shares)         1,239,647    
Warrant is exercisable years     5 years   5 years    
Exercise price (in Dollars per share)         $ 1.25    
Private Placement [Member]              
Equity (Details) [Line Items]              
Dividend yield         0.00%    
Expected life         5 years    
Convertible notes payable     $ 498,509   $ 498,509    
Warrants issued investor to purchase shares (in Shares)         1,239,647    
Private Placement [Member] | Minimum [Member]              
Equity (Details) [Line Items]              
Risk-free rate         2.71%    
Private Placement [Member] | Maximum [Member]              
Equity (Details) [Line Items]              
Risk-free rate         2.92%    
Common Stock [Member]              
Equity (Details) [Line Items]              
Common stock, issued (in Shares) 448,718   350,000   350,000    
Purchase price (in Dollars per share) $ 0.78            
Received proceeds $ 350,000            
Black-Scholes option-pricing [Member]              
Equity (Details) [Line Items]              
Aggregate fair value     $ 373,982   $ 373,982    
2022 Convertible Note [Member]              
Equity (Details) [Line Items]              
Convertible notes payable             $ 3,718,943
Jefferies LLC [Member]              
Equity (Details) [Line Items]              
Aggregate shares (in Shares)         170,640    
Share price (in Dollars per share)     $ 0.79   $ 0.79    
Net proceeds         $ 112,328    
Net of commission and other offering costs         23,239    
Compensation and Related Benefits [Member]              
Equity (Details) [Line Items]              
Stock-based compensation expense     $ 87,300 134,833 285,384 $ 410,732  
Professional Fees [Member]              
Equity (Details) [Line Items]              
Stock-based compensation expense     14,121 37,596 71,719 120,584  
Research and Development Expense [Member]              
Equity (Details) [Line Items]              
Stock-based compensation expense     $ 9,021 $ 16,430 $ 31,963 $ 55,257